This website is intended for healthcare professionals

Non-medical prescribing in primary care in the United Kingdom: an overview of the current literature

The primary focus of the research in NMP to date has been on its impact on patients, practitioners and organisations (Courtenay et al, 2018; Carey et al, 2020). Other studies have identified...

Living with long COVID

The new guideline for NICE (2021) recommends that patients presenting with new or ongoing symptoms 4 weeks or later after an initial COVID-19 infection should have the following investigations done; a...

Understanding personal asthma action plans

The National Review of Asthma Deaths (NRAD) (Royal College of Physicians, 2014) investigated the clinical records of 195 adults and children who died of asthma between February 2012 and January 2013....

Maintaining safe practice

I don't know about you, but I find it difficult when reading news and updates these days not to see COVID-19 everywhere I look! But a few non-COVID things have caught my eye this month, and one...

Drug Updates: August

Enzalutamide plus androgen deprivation therapy (ADT) is recommended by NICE, within its marketing authorisation, as an option for treating hormone-sensitive metastatic prostate cancer in adults.

Drug breakdown and Continued professional developement: Memantine

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate.

The use of St John's Wort and its many interactions

St John's Wort is a herbal remedy that has been around for hundreds of years to treat mental health problems, and currently is bought over the counter for mild-to-moderate depression, as well as for...

Antimicrobial prescribing and stewardship

This mixed methods study using a reasoned action approach in the Journal of Hospital Infection aimed to measure nurse independent prescribers' (NIPs) intention to manage patients, presenting with an...

Understanding ivermectin

When the implications of the unfolding COVID-19 pandemic dawned, the race for effective vaccines and/or treatments began. However, as Dinis-Oliveira (2020) notes, the scientific approach ranged ‘from...

Fungal skin infections

Fungal infections caused by dermatophytes, a group of fungi that invade and grow in dead keratin, causing infection that is normally confined to dead layers of skin. Because dermatophytes require...

Nutrition and oncology: best practice and the development of a traffic light system

Multidisciplinary working is vital to proactively manage the nutritional care of oncology patients, whether this is via oral nutritional support or prophylactic/reactive enteral feeding..

Understanding primary prevention of cardiovascular disease

The NHS Health Check programme was designed to identify people with risk factors for CVD and ensure that they had access to the support and medication they might need to reduce that risk (Waterall,...

Emergency contraception

‘Harrison (2005) telephoned hundreds of both Catholic and non-Catholic hospitals in the United States, asking about EHC availability. She found that almost half of hospital emergency departments (42%...

Medicines reconciliation of biologics on a primary care clinical system

DMARDs (Disease Modifying Anti-Rheumatic Drugs) such as methotrexate, azathioprine and leflunomide, licensed in dermatological, gastrointestinal and rheumatic conditions are not strictly biologics....

Take Pride in your progress

In a year of news about COVID-19, it is easy for a genuinely exciting development like the topic of this month's editorial to get lost in the relentless news cycle of late. I don't think I myself have...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP